J18127 PSMA PyL 18F-DCFPyL PET/CT
Showing 1 - 25 of 9,625
Prostate Cancer Trial in Baltimore (18F-DCFPyL Injection)
Active, not recruiting
- Prostate Cancer
- 18F-DCFPyL Injection
-
Baltimore, MarylandSKCCC
Apr 5, 2022
Prostate Cancer Trial (Pylarify Piflufolastat Flourine-18 (18F-DCFPyL))
Not yet recruiting
- Prostate Cancer
- Pylarify Piflufolastat Flourine-18 (18F-DCFPyL)
- (no location specified)
Jan 26, 2023
Carcinoma of Prostate Trial in Toronto (18F-DCFPyL)
Active, not recruiting
- Carcinoma of Prostate
- 18F-DCFPyL
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Oct 31, 2022
Schwannomas, Malignant Tumors Trial in Baltimore (18F-DCFPyL Injection)
Completed
- Schwannomas
- Malignant Tumors
- 18F-DCFPyL Injection
-
Baltimore, MarylandJohns Hopkins University
Jan 9, 2023
Prostate Cancer Trial in Baltimore (18F-DCFPyL Injection)
Completed
- Prostate Cancer
- 18F-DCFPyL Injection
-
Baltimore, MarylandJohns Hopkins University
Dec 14, 2021
Metastatic Prostate Cancer Trial in New York ([F-18] DCFPyL, PET/CT imaging)
Active, not recruiting
- Metastatic Prostate Cancer
- [F-18] DCFPyL
- PET/CT imaging
-
New York, New YorkColumbia University Irving Medical Center
May 6, 2022
Prostate Cancer Diagnosis Trial in Los Angeles (diagnostic test, other, drug)
Not yet recruiting
- Prostate Cancer Diagnosis
- PSMA PET scan
- +2 more
-
Los Angeles, CaliforniaVA Greater Los Angeles Healthcare System
Apr 20, 2023
Prostate Cancer, Newly-Diagnosed Prostate Cancer Trial ([18F]PSMA-1007)
Not yet recruiting
- Prostate Cancer
- Newly-Diagnosed Prostate Cancer
- (no location specified)
Nov 3, 2023
Prostate Cancer Trial in Beijing (Al18F-PSMA-617, 68Ga-PSMA-617)
Recruiting
- Prostate Cancer
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
May 2, 2023
Malignancy Trial in Beijing (Al18F-PSMA-BCH PET/CT)
Recruiting
- Malignancy
- Al18F-PSMA-BCH PET/CT
-
Beijing, Chaoyang, ChinaNational Cancer Center/Cancer Hospital,Chinese Academy of Medica
Mar 7, 2023
Prostate Tumors, Prostatic Cancer, Prostate Cancer Trial run by the National Cancer Institute (NCI) (18F-DCFPyL, 18F-FDG,
Enrolling by invitation
- Prostate Neoplasms
- +4 more
- 18F-DCFPyL
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 17, 2022
Prostate Carcinoma Trial in Duarte (procedure, other, device)
Recruiting
- Prostate Carcinoma
- Computed Tomography
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 15, 2022
Advanced Prostate Cancer, Metastatic Prostate Cancer, Metastatic Prostate Neuroendocrine Carcinoma Trial in Boston
Not yet recruiting
- Advanced Prostate Cancer
- +2 more
- 18F-fluciclovine
- PET/CT
-
Boston, Massachusetts
- +1 more
Sep 25, 2023
Prostatic Tumors Trial in New York (18F- DCFPyL PET/CT)
Active, not recruiting
- Prostatic Neoplasms
- 18F- DCFPyL PET/CT
-
New York, New YorkColumbia University Irving Medical Center
May 6, 2022
Prostate Cancer Trial in Québec (Enzalutamide capsule)
Recruiting
- Prostate Cancer
- Enzalutamide capsule
-
Québec, CanadaCHU de Québec-Université Laval
Mar 29, 2022
Prostate Cancer Trial ([18F]-PSMA-1007)
Not yet recruiting
- Prostate Cancer
- [18F]-PSMA-1007
- (no location specified)
Jan 30, 2023
Castration Resistant Prostate Cancer, Castration Sensitive Prostate Cancer Trial in Portland (drug, procedure, other)
Not yet recruiting
- Castration Resistant Prostate Cancer
- Castration Sensitive Prostate Cancer
- Piflufolastat
- +4 more
-
Portland, OregonOHSU Knight Cancer Institute
Jun 16, 2023
Multiple Myeloma Trial in Shenyang (18F-PSMA-1007, 18F-FDG)
Recruiting
- Multiple Myeloma
-
Shenyang, Liaoning, ChinaThe First Affiliated Hospital of China Medical University
Jul 6, 2022
Prostate Cancer Trial in Hefei (18F-PSMA-1007 PET/CT based on diagnostic model)
Not yet recruiting
- Prostate Cancer
- 18F-PSMA-1007 PET/CT based on diagnostic model
-
Hefei, Anhui, ChinaThe First Affiliated Hospital of USTC
Dec 6, 2022
Breast Cancer, HER2-negative Breast Cancer, Metastatic Breast Cancer Trial in Madison (18F-DCFPyL)
Recruiting
- Breast Cancer
- +2 more
-
Madison, WisconsinUniversity of Wisconsin School of Medicine and Public Health
Oct 18, 2022
Prostate Cancer Trial in Montreal (18F-DCFPyL PET/CT)
Enrolling by invitation
- Prostate Cancer
- 18F-DCFPyL PET/CT
-
Montreal, Quebec, CanadaJewish General Hospital
May 3, 2022
Prostate Carcinoma Trial in Chicago (Fluorine F 18 DCFPyL, Gadobenate Dimeglumine, Gadobutrol)
Not yet recruiting
- Prostate Carcinoma
- Fluorine F 18 DCFPyL
- +6 more
-
Chicago, IllinoisNorthwestern University
Aug 2, 2022
Prostate Cancer Trial in Baltimore (18F-DCFPyL Injection)
Withdrawn
- Prostate Cancer
- 18F-DCFPyL Injection
-
Baltimore, MarylandJohns Hopkins University
Dec 14, 2021
Prostate Cancer Trial in Edmonton (18F-PSMA-1007)
Active, not recruiting
- Prostate Cancer
- 18F-PSMA-1007
-
Edmonton, Alberta, CanadaUniversity of Alberta
Aug 10, 2022